Jonathan M. Carlson

February 24, 2025

Microsoft's generative artificial intelligence is making it possible to identify patterns in large populations, structure clinical information and simulate clinical trials, optimizing the development of new treatments.

May 22, 2024

Microsoft is delving even deeper into clinical medicine, evident by the announcement today highlighting the company’s development of a foundation model for pathology in partnership with Providence and the University of Washington. Specifically, the company has leveraged its significant work…

February 1, 2023

AI has a massive role to play in the big leaps ahead for biotech and human health from enabling us to explore biology in ways never before possible to speeding up the pace at which we discover and deliver new…

November 18, 2021

Microsoft and Adaptive Biotech - For using data to create a test for past COVID-19 infection | The tech giant teamed up with Adaptive Biotech to create ImmuneCODE, an open-source database of immune responses to COVID-19, which they used to…

May 30, 2019

In 2017, Microsoft struck a deal with Seattle-based Adaptive Biotechnologies to develop a blood test with the promise of diagnosing dozens of diseases at once, and as part of the agreement, pledged to invest an undisclosed amount in the company. Adaptive filed…

January 3, 2019

Decoding nature's antigen map requires immunological data of a scale never-before generated, coupled with new algorithmic approaches to modeling how T-cells bind to antigens.

October 9, 2018

Every day, thousands of people cross the 520 bridge between Seattle and Bellevue, Wash. But for some of those people, the daily journey is more than just a commute: It is part of a years-long project to create a completely…

January 4, 2018

Microsoft and Adaptive Biotechnologies hope to pair advances in AI and machine learning with recent breakthroughs in biotechnology to map out the immune system and tap into the body's impressive diagnostic system.

March 30, 2017

The HIV Vaccine Trials Network honored Jonathan Carlson with an inaugural Bonnie Mathieson Young Investigator Award for his leading role in research that leveraged machine learning and the trials network’s data to show how HIV variants that are pre-adapted to an individual’s immune…